nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA5B—coronary artery disease	0.287	1	CbGaD
Metolazone—Indapamide—Furosemide—coronary artery disease	0.286	1	CrCrCtD
Metolazone—CA5A—Furosemide—coronary artery disease	0.0502	0.204	CbGbCtD
Metolazone—CA5B—Furosemide—coronary artery disease	0.0438	0.178	CbGbCtD
Metolazone—CA7—Furosemide—coronary artery disease	0.0438	0.178	CbGbCtD
Metolazone—CA9—Furosemide—coronary artery disease	0.0376	0.153	CbGbCtD
Metolazone—CA12—Furosemide—coronary artery disease	0.0376	0.153	CbGbCtD
Metolazone—CA4—Furosemide—coronary artery disease	0.0331	0.134	CbGbCtD
Metolazone—CA5B—cervicothoracic ganglion—coronary artery disease	0.0138	0.514	CbGeAlD
Metolazone—CA5B—sinoatrial node—coronary artery disease	0.00892	0.331	CbGeAlD
Metolazone—Indapamide—CA5B—coronary artery disease	0.000821	0.537	CrCbGaD
Metolazone—Chlorthalidone—CA5B—coronary artery disease	0.000706	0.463	CrCbGaD
Metolazone—CA4—cardiac ventricle—coronary artery disease	0.000546	0.0203	CbGeAlD
Metolazone—CA5B—heart—coronary artery disease	0.00052	0.0193	CbGeAlD
Metolazone—CA4—myocardium—coronary artery disease	0.000514	0.0191	CbGeAlD
Metolazone—CA5B—cardiovascular system—coronary artery disease	0.00049	0.0182	CbGeAlD
Metolazone—CA5B—cardiac atrium—coronary artery disease	0.000445	0.0165	CbGeAlD
Metolazone—CA5B—blood—coronary artery disease	0.000388	0.0144	CbGeAlD
Metolazone—CA4—heart—coronary artery disease	0.000359	0.0133	CbGeAlD
Metolazone—CA4—cardiovascular system—coronary artery disease	0.000339	0.0126	CbGeAlD
Metolazone—CA4—cardiac atrium—coronary artery disease	0.000307	0.0114	CbGeAlD
Metolazone—CA4—blood—coronary artery disease	0.000268	0.00994	CbGeAlD
Metolazone—Somnolence—Losartan—coronary artery disease	4.42e-05	0.000408	CcSEcCtD
Metolazone—Dizziness—Eplerenone—coronary artery disease	4.42e-05	0.000408	CcSEcCtD
Metolazone—Rash—Clopidogrel—coronary artery disease	4.42e-05	0.000408	CcSEcCtD
Metolazone—Dermatitis—Clopidogrel—coronary artery disease	4.41e-05	0.000408	CcSEcCtD
Metolazone—Asthenia—Valsartan—coronary artery disease	4.41e-05	0.000407	CcSEcCtD
Metolazone—Hypertension—Timolol—coronary artery disease	4.41e-05	0.000407	CcSEcCtD
Metolazone—Pain—Furosemide—coronary artery disease	4.41e-05	0.000407	CcSEcCtD
Metolazone—Constipation—Furosemide—coronary artery disease	4.41e-05	0.000407	CcSEcCtD
Metolazone—Hypersensitivity—Niacin—coronary artery disease	4.4e-05	0.000407	CcSEcCtD
Metolazone—Ill-defined disorder—Lisinopril—coronary artery disease	4.4e-05	0.000406	CcSEcCtD
Metolazone—Discomfort—Ramipril—coronary artery disease	4.39e-05	0.000406	CcSEcCtD
Metolazone—Asthenia—Olmesartan—coronary artery disease	4.39e-05	0.000405	CcSEcCtD
Metolazone—Headache—Clopidogrel—coronary artery disease	4.39e-05	0.000405	CcSEcCtD
Metolazone—Rash—Lovastatin—coronary artery disease	4.39e-05	0.000405	CcSEcCtD
Metolazone—Dermatitis—Lovastatin—coronary artery disease	4.38e-05	0.000405	CcSEcCtD
Metolazone—Anaemia—Lisinopril—coronary artery disease	4.38e-05	0.000404	CcSEcCtD
Metolazone—Dyspepsia—Losartan—coronary artery disease	4.38e-05	0.000404	CcSEcCtD
Metolazone—Feeling abnormal—Perindopril—coronary artery disease	4.37e-05	0.000403	CcSEcCtD
Metolazone—Headache—Lovastatin—coronary artery disease	4.36e-05	0.000403	CcSEcCtD
Metolazone—Pruritus—Valsartan—coronary artery disease	4.35e-05	0.000402	CcSEcCtD
Metolazone—Dry mouth—Ramipril—coronary artery disease	4.35e-05	0.000402	CcSEcCtD
Metolazone—Chest pain—Timolol—coronary artery disease	4.35e-05	0.000402	CcSEcCtD
Metolazone—Arthralgia—Timolol—coronary artery disease	4.35e-05	0.000402	CcSEcCtD
Metolazone—Vomiting—Ezetimibe—coronary artery disease	4.34e-05	0.000401	CcSEcCtD
Metolazone—Hypersensitivity—Pravastatin—coronary artery disease	4.34e-05	0.0004	CcSEcCtD
Metolazone—Gastrointestinal pain—Perindopril—coronary artery disease	4.34e-05	0.0004	CcSEcCtD
Metolazone—Anxiety—Timolol—coronary artery disease	4.33e-05	0.0004	CcSEcCtD
Metolazone—Pruritus—Olmesartan—coronary artery disease	4.33e-05	0.0004	CcSEcCtD
Metolazone—Decreased appetite—Losartan—coronary artery disease	4.32e-05	0.000399	CcSEcCtD
Metolazone—Abdominal pain—Captopril—coronary artery disease	4.32e-05	0.000399	CcSEcCtD
Metolazone—Dizziness—Simvastatin—coronary artery disease	4.31e-05	0.000398	CcSEcCtD
Metolazone—Rash—Ezetimibe—coronary artery disease	4.3e-05	0.000397	CcSEcCtD
Metolazone—Dermatitis—Ezetimibe—coronary artery disease	4.3e-05	0.000397	CcSEcCtD
Metolazone—Discomfort—Timolol—coronary artery disease	4.3e-05	0.000397	CcSEcCtD
Metolazone—Asthenia—Niacin—coronary artery disease	4.29e-05	0.000396	CcSEcCtD
Metolazone—Fatigue—Losartan—coronary artery disease	4.29e-05	0.000396	CcSEcCtD
Metolazone—Headache—Ezetimibe—coronary artery disease	4.28e-05	0.000395	CcSEcCtD
Metolazone—Malaise—Lisinopril—coronary artery disease	4.27e-05	0.000395	CcSEcCtD
Metolazone—Vertigo—Lisinopril—coronary artery disease	4.26e-05	0.000393	CcSEcCtD
Metolazone—Dry mouth—Timolol—coronary artery disease	4.25e-05	0.000393	CcSEcCtD
Metolazone—Pain—Losartan—coronary artery disease	4.25e-05	0.000393	CcSEcCtD
Metolazone—Constipation—Losartan—coronary artery disease	4.25e-05	0.000393	CcSEcCtD
Metolazone—Syncope—Lisinopril—coronary artery disease	4.25e-05	0.000392	CcSEcCtD
Metolazone—Vomiting—Eplerenone—coronary artery disease	4.25e-05	0.000392	CcSEcCtD
Metolazone—Feeling abnormal—Furosemide—coronary artery disease	4.25e-05	0.000392	CcSEcCtD
Metolazone—Leukopenia—Lisinopril—coronary artery disease	4.24e-05	0.000392	CcSEcCtD
Metolazone—Nausea—Fenofibrate—coronary artery disease	4.23e-05	0.000391	CcSEcCtD
Metolazone—Pruritus—Niacin—coronary artery disease	4.23e-05	0.000391	CcSEcCtD
Metolazone—Asthenia—Pravastatin—coronary artery disease	4.22e-05	0.00039	CcSEcCtD
Metolazone—Gastrointestinal pain—Furosemide—coronary artery disease	4.21e-05	0.000389	CcSEcCtD
Metolazone—Rash—Eplerenone—coronary artery disease	4.21e-05	0.000389	CcSEcCtD
Metolazone—Urticaria—Perindopril—coronary artery disease	4.21e-05	0.000389	CcSEcCtD
Metolazone—Hypersensitivity—Trandolapril—coronary artery disease	4.21e-05	0.000389	CcSEcCtD
Metolazone—Dermatitis—Eplerenone—coronary artery disease	4.21e-05	0.000389	CcSEcCtD
Metolazone—Diarrhoea—Valsartan—coronary artery disease	4.21e-05	0.000388	CcSEcCtD
Metolazone—Shock—Ramipril—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Hypersensitivity—Enalapril—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Abdominal pain—Perindopril—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Palpitations—Lisinopril—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Diarrhoea—Olmesartan—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Headache—Eplerenone—coronary artery disease	4.19e-05	0.000387	CcSEcCtD
Metolazone—Thrombocytopenia—Ramipril—coronary artery disease	4.17e-05	0.000385	CcSEcCtD
Metolazone—Pruritus—Pravastatin—coronary artery disease	4.16e-05	0.000385	CcSEcCtD
Metolazone—Loss of consciousness—Lisinopril—coronary artery disease	4.16e-05	0.000385	CcSEcCtD
Metolazone—Nausea—Clopidogrel—coronary artery disease	4.16e-05	0.000384	CcSEcCtD
Metolazone—Vomiting—Simvastatin—coronary artery disease	4.14e-05	0.000382	CcSEcCtD
Metolazone—Hypersensitivity—Telmisartan—coronary artery disease	4.14e-05	0.000382	CcSEcCtD
Metolazone—Cough—Lisinopril—coronary artery disease	4.13e-05	0.000382	CcSEcCtD
Metolazone—Nausea—Lovastatin—coronary artery disease	4.13e-05	0.000382	CcSEcCtD
Metolazone—Rash—Simvastatin—coronary artery disease	4.11e-05	0.000379	CcSEcCtD
Metolazone—Dermatitis—Simvastatin—coronary artery disease	4.1e-05	0.000379	CcSEcCtD
Metolazone—Asthenia—Trandolapril—coronary artery disease	4.1e-05	0.000379	CcSEcCtD
Metolazone—Shock—Timolol—coronary artery disease	4.1e-05	0.000379	CcSEcCtD
Metolazone—Feeling abnormal—Losartan—coronary artery disease	4.1e-05	0.000378	CcSEcCtD
Metolazone—Urticaria—Furosemide—coronary artery disease	4.09e-05	0.000378	CcSEcCtD
Metolazone—Diarrhoea—Niacin—coronary artery disease	4.09e-05	0.000378	CcSEcCtD
Metolazone—Asthenia—Enalapril—coronary artery disease	4.08e-05	0.000377	CcSEcCtD
Metolazone—Headache—Simvastatin—coronary artery disease	4.08e-05	0.000377	CcSEcCtD
Metolazone—Abdominal pain—Furosemide—coronary artery disease	4.07e-05	0.000376	CcSEcCtD
Metolazone—Gastrointestinal pain—Losartan—coronary artery disease	4.07e-05	0.000375	CcSEcCtD
Metolazone—Dizziness—Valsartan—coronary artery disease	4.07e-05	0.000375	CcSEcCtD
Metolazone—Anorexia—Ramipril—coronary artery disease	4.06e-05	0.000375	CcSEcCtD
Metolazone—Nausea—Ezetimibe—coronary artery disease	4.06e-05	0.000374	CcSEcCtD
Metolazone—Dizziness—Olmesartan—coronary artery disease	4.05e-05	0.000374	CcSEcCtD
Metolazone—Pruritus—Trandolapril—coronary artery disease	4.04e-05	0.000373	CcSEcCtD
Metolazone—Chest pain—Lisinopril—coronary artery disease	4.03e-05	0.000372	CcSEcCtD
Metolazone—Arthralgia—Lisinopril—coronary artery disease	4.03e-05	0.000372	CcSEcCtD
Metolazone—Asthenia—Telmisartan—coronary artery disease	4.03e-05	0.000372	CcSEcCtD
Metolazone—Pruritus—Enalapril—coronary artery disease	4.03e-05	0.000372	CcSEcCtD
Metolazone—Diarrhoea—Pravastatin—coronary artery disease	4.03e-05	0.000372	CcSEcCtD
Metolazone—Anxiety—Lisinopril—coronary artery disease	4.02e-05	0.000371	CcSEcCtD
Metolazone—Discomfort—Lisinopril—coronary artery disease	3.99e-05	0.000368	CcSEcCtD
Metolazone—Anorexia—Timolol—coronary artery disease	3.97e-05	0.000367	CcSEcCtD
Metolazone—Pruritus—Telmisartan—coronary artery disease	3.97e-05	0.000367	CcSEcCtD
Metolazone—Nausea—Eplerenone—coronary artery disease	3.97e-05	0.000367	CcSEcCtD
Metolazone—Dizziness—Niacin—coronary artery disease	3.95e-05	0.000365	CcSEcCtD
Metolazone—Urticaria—Losartan—coronary artery disease	3.95e-05	0.000365	CcSEcCtD
Metolazone—Dry mouth—Lisinopril—coronary artery disease	3.95e-05	0.000364	CcSEcCtD
Metolazone—Abdominal pain—Losartan—coronary artery disease	3.93e-05	0.000363	CcSEcCtD
Metolazone—Asthenia—Captopril—coronary artery disease	3.92e-05	0.000362	CcSEcCtD
Metolazone—Diarrhoea—Trandolapril—coronary artery disease	3.91e-05	0.000361	CcSEcCtD
Metolazone—Vomiting—Valsartan—coronary artery disease	3.91e-05	0.000361	CcSEcCtD
Metolazone—Diarrhoea—Enalapril—coronary artery disease	3.9e-05	0.00036	CcSEcCtD
Metolazone—Dizziness—Pravastatin—coronary artery disease	3.89e-05	0.000359	CcSEcCtD
Metolazone—Vomiting—Olmesartan—coronary artery disease	3.89e-05	0.000359	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.88e-05	0.000359	CcSEcCtD
Metolazone—Rash—Valsartan—coronary artery disease	3.88e-05	0.000358	CcSEcCtD
Metolazone—Dermatitis—Valsartan—coronary artery disease	3.87e-05	0.000358	CcSEcCtD
Metolazone—Nausea—Simvastatin—coronary artery disease	3.87e-05	0.000357	CcSEcCtD
Metolazone—Pruritus—Captopril—coronary artery disease	3.86e-05	0.000357	CcSEcCtD
Metolazone—Rash—Olmesartan—coronary artery disease	3.86e-05	0.000356	CcSEcCtD
Metolazone—Insomnia—Ramipril—coronary artery disease	3.86e-05	0.000356	CcSEcCtD
Metolazone—Dermatitis—Olmesartan—coronary artery disease	3.85e-05	0.000356	CcSEcCtD
Metolazone—Headache—Valsartan—coronary artery disease	3.85e-05	0.000356	CcSEcCtD
Metolazone—Diarrhoea—Telmisartan—coronary artery disease	3.84e-05	0.000355	CcSEcCtD
Metolazone—Headache—Olmesartan—coronary artery disease	3.83e-05	0.000354	CcSEcCtD
Metolazone—Paraesthesia—Ramipril—coronary artery disease	3.83e-05	0.000354	CcSEcCtD
Metolazone—Shock—Lisinopril—coronary artery disease	3.8e-05	0.000351	CcSEcCtD
Metolazone—Asthenia—Perindopril—coronary artery disease	3.8e-05	0.000351	CcSEcCtD
Metolazone—Vomiting—Niacin—coronary artery disease	3.8e-05	0.000351	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Timolol—coronary artery disease	3.8e-05	0.000351	CcSEcCtD
Metolazone—Hypersensitivity—Furosemide—coronary artery disease	3.8e-05	0.000351	CcSEcCtD
Metolazone—Somnolence—Ramipril—coronary artery disease	3.79e-05	0.00035	CcSEcCtD
Metolazone—Thrombocytopenia—Lisinopril—coronary artery disease	3.79e-05	0.00035	CcSEcCtD
Metolazone—Dizziness—Trandolapril—coronary artery disease	3.78e-05	0.000349	CcSEcCtD
Metolazone—Insomnia—Timolol—coronary artery disease	3.77e-05	0.000348	CcSEcCtD
Metolazone—Rash—Niacin—coronary artery disease	3.77e-05	0.000348	CcSEcCtD
Metolazone—Dermatitis—Niacin—coronary artery disease	3.77e-05	0.000348	CcSEcCtD
Metolazone—Dizziness—Enalapril—coronary artery disease	3.76e-05	0.000348	CcSEcCtD
Metolazone—Dyspepsia—Ramipril—coronary artery disease	3.75e-05	0.000347	CcSEcCtD
Metolazone—Pruritus—Perindopril—coronary artery disease	3.75e-05	0.000346	CcSEcCtD
Metolazone—Headache—Niacin—coronary artery disease	3.75e-05	0.000346	CcSEcCtD
Metolazone—Paraesthesia—Timolol—coronary artery disease	3.74e-05	0.000346	CcSEcCtD
Metolazone—Vomiting—Pravastatin—coronary artery disease	3.74e-05	0.000346	CcSEcCtD
Metolazone—Diarrhoea—Captopril—coronary artery disease	3.74e-05	0.000345	CcSEcCtD
Metolazone—Dizziness—Telmisartan—coronary artery disease	3.71e-05	0.000343	CcSEcCtD
Metolazone—Rash—Pravastatin—coronary artery disease	3.71e-05	0.000343	CcSEcCtD
Metolazone—Dermatitis—Pravastatin—coronary artery disease	3.71e-05	0.000342	CcSEcCtD
Metolazone—Decreased appetite—Ramipril—coronary artery disease	3.71e-05	0.000342	CcSEcCtD
Metolazone—Somnolence—Timolol—coronary artery disease	3.71e-05	0.000342	CcSEcCtD
Metolazone—Asthenia—Furosemide—coronary artery disease	3.7e-05	0.000341	CcSEcCtD
Metolazone—Headache—Pravastatin—coronary artery disease	3.69e-05	0.00034	CcSEcCtD
Metolazone—Anorexia—Lisinopril—coronary artery disease	3.69e-05	0.00034	CcSEcCtD
Metolazone—Fatigue—Ramipril—coronary artery disease	3.68e-05	0.000339	CcSEcCtD
Metolazone—Dyspepsia—Timolol—coronary artery disease	3.67e-05	0.000339	CcSEcCtD
Metolazone—Hypersensitivity—Losartan—coronary artery disease	3.66e-05	0.000338	CcSEcCtD
Metolazone—Nausea—Valsartan—coronary artery disease	3.65e-05	0.000337	CcSEcCtD
Metolazone—Pruritus—Furosemide—coronary artery disease	3.65e-05	0.000337	CcSEcCtD
Metolazone—Constipation—Ramipril—coronary artery disease	3.65e-05	0.000337	CcSEcCtD
Metolazone—Nausea—Olmesartan—coronary artery disease	3.63e-05	0.000336	CcSEcCtD
Metolazone—Vomiting—Trandolapril—coronary artery disease	3.63e-05	0.000336	CcSEcCtD
Metolazone—Diarrhoea—Perindopril—coronary artery disease	3.63e-05	0.000335	CcSEcCtD
Metolazone—Decreased appetite—Timolol—coronary artery disease	3.62e-05	0.000335	CcSEcCtD
Metolazone—Vomiting—Enalapril—coronary artery disease	3.62e-05	0.000334	CcSEcCtD
Metolazone—Dizziness—Captopril—coronary artery disease	3.61e-05	0.000333	CcSEcCtD
Metolazone—Rash—Trandolapril—coronary artery disease	3.6e-05	0.000333	CcSEcCtD
Metolazone—Dermatitis—Trandolapril—coronary artery disease	3.6e-05	0.000332	CcSEcCtD
Metolazone—Fatigue—Timolol—coronary artery disease	3.59e-05	0.000332	CcSEcCtD
Metolazone—Rash—Enalapril—coronary artery disease	3.59e-05	0.000331	CcSEcCtD
Metolazone—Dermatitis—Enalapril—coronary artery disease	3.59e-05	0.000331	CcSEcCtD
Metolazone—Headache—Trandolapril—coronary artery disease	3.58e-05	0.000331	CcSEcCtD
Metolazone—Vomiting—Telmisartan—coronary artery disease	3.57e-05	0.00033	CcSEcCtD
Metolazone—Asthenia—Losartan—coronary artery disease	3.57e-05	0.000329	CcSEcCtD
Metolazone—Headache—Enalapril—coronary artery disease	3.57e-05	0.000329	CcSEcCtD
Metolazone—Pain—Timolol—coronary artery disease	3.56e-05	0.000329	CcSEcCtD
Metolazone—Nausea—Niacin—coronary artery disease	3.55e-05	0.000328	CcSEcCtD
Metolazone—Rash—Telmisartan—coronary artery disease	3.54e-05	0.000327	CcSEcCtD
Metolazone—Dermatitis—Telmisartan—coronary artery disease	3.54e-05	0.000327	CcSEcCtD
Metolazone—Diarrhoea—Furosemide—coronary artery disease	3.53e-05	0.000326	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.52e-05	0.000325	CcSEcCtD
Metolazone—Pruritus—Losartan—coronary artery disease	3.52e-05	0.000325	CcSEcCtD
Metolazone—Headache—Telmisartan—coronary artery disease	3.52e-05	0.000325	CcSEcCtD
Metolazone—Feeling abnormal—Ramipril—coronary artery disease	3.51e-05	0.000324	CcSEcCtD
Metolazone—Dizziness—Perindopril—coronary artery disease	3.51e-05	0.000324	CcSEcCtD
Metolazone—Insomnia—Lisinopril—coronary artery disease	3.5e-05	0.000323	CcSEcCtD
Metolazone—Nausea—Pravastatin—coronary artery disease	3.5e-05	0.000323	CcSEcCtD
Metolazone—Gastrointestinal pain—Ramipril—coronary artery disease	3.49e-05	0.000322	CcSEcCtD
Metolazone—Paraesthesia—Lisinopril—coronary artery disease	3.47e-05	0.000321	CcSEcCtD
Metolazone—Vomiting—Captopril—coronary artery disease	3.47e-05	0.000321	CcSEcCtD
Metolazone—Rash—Captopril—coronary artery disease	3.44e-05	0.000318	CcSEcCtD
Metolazone—Dermatitis—Captopril—coronary artery disease	3.44e-05	0.000318	CcSEcCtD
Metolazone—Somnolence—Lisinopril—coronary artery disease	3.44e-05	0.000317	CcSEcCtD
Metolazone—Feeling abnormal—Timolol—coronary artery disease	3.43e-05	0.000317	CcSEcCtD
Metolazone—Headache—Captopril—coronary artery disease	3.42e-05	0.000316	CcSEcCtD
Metolazone—Gastrointestinal pain—Timolol—coronary artery disease	3.41e-05	0.000315	CcSEcCtD
Metolazone—Dizziness—Furosemide—coronary artery disease	3.41e-05	0.000315	CcSEcCtD
Metolazone—Dyspepsia—Lisinopril—coronary artery disease	3.4e-05	0.000314	CcSEcCtD
Metolazone—Diarrhoea—Losartan—coronary artery disease	3.4e-05	0.000314	CcSEcCtD
Metolazone—Nausea—Trandolapril—coronary artery disease	3.4e-05	0.000314	CcSEcCtD
Metolazone—Urticaria—Ramipril—coronary artery disease	3.39e-05	0.000313	CcSEcCtD
Metolazone—Nausea—Enalapril—coronary artery disease	3.38e-05	0.000312	CcSEcCtD
Metolazone—Vomiting—Perindopril—coronary artery disease	3.37e-05	0.000311	CcSEcCtD
Metolazone—Abdominal pain—Ramipril—coronary artery disease	3.37e-05	0.000311	CcSEcCtD
Metolazone—Decreased appetite—Lisinopril—coronary artery disease	3.36e-05	0.00031	CcSEcCtD
Metolazone—Rash—Perindopril—coronary artery disease	3.34e-05	0.000309	CcSEcCtD
Metolazone—Dermatitis—Perindopril—coronary artery disease	3.34e-05	0.000308	CcSEcCtD
Metolazone—Nausea—Telmisartan—coronary artery disease	3.34e-05	0.000308	CcSEcCtD
Metolazone—Fatigue—Lisinopril—coronary artery disease	3.33e-05	0.000308	CcSEcCtD
Metolazone—Headache—Perindopril—coronary artery disease	3.32e-05	0.000307	CcSEcCtD
Metolazone—Urticaria—Timolol—coronary artery disease	3.31e-05	0.000306	CcSEcCtD
Metolazone—Constipation—Lisinopril—coronary artery disease	3.31e-05	0.000305	CcSEcCtD
Metolazone—Pain—Lisinopril—coronary artery disease	3.31e-05	0.000305	CcSEcCtD
Metolazone—Abdominal pain—Timolol—coronary artery disease	3.3e-05	0.000304	CcSEcCtD
Metolazone—Dizziness—Losartan—coronary artery disease	3.29e-05	0.000304	CcSEcCtD
Metolazone—Vomiting—Furosemide—coronary artery disease	3.28e-05	0.000303	CcSEcCtD
Metolazone—Rash—Furosemide—coronary artery disease	3.25e-05	0.0003	CcSEcCtD
Metolazone—Dermatitis—Furosemide—coronary artery disease	3.25e-05	0.0003	CcSEcCtD
Metolazone—Nausea—Captopril—coronary artery disease	3.24e-05	0.000299	CcSEcCtD
Metolazone—Headache—Furosemide—coronary artery disease	3.23e-05	0.000298	CcSEcCtD
Metolazone—Feeling abnormal—Lisinopril—coronary artery disease	3.19e-05	0.000294	CcSEcCtD
Metolazone—Gastrointestinal pain—Lisinopril—coronary artery disease	3.16e-05	0.000292	CcSEcCtD
Metolazone—Vomiting—Losartan—coronary artery disease	3.16e-05	0.000292	CcSEcCtD
Metolazone—Nausea—Perindopril—coronary artery disease	3.15e-05	0.000291	CcSEcCtD
Metolazone—Hypersensitivity—Ramipril—coronary artery disease	3.14e-05	0.00029	CcSEcCtD
Metolazone—Rash—Losartan—coronary artery disease	3.14e-05	0.00029	CcSEcCtD
Metolazone—Dermatitis—Losartan—coronary artery disease	3.13e-05	0.000289	CcSEcCtD
Metolazone—Headache—Losartan—coronary artery disease	3.12e-05	0.000288	CcSEcCtD
Metolazone—Urticaria—Lisinopril—coronary artery disease	3.07e-05	0.000284	CcSEcCtD
Metolazone—Hypersensitivity—Timolol—coronary artery disease	3.07e-05	0.000284	CcSEcCtD
Metolazone—Nausea—Furosemide—coronary artery disease	3.06e-05	0.000283	CcSEcCtD
Metolazone—Asthenia—Ramipril—coronary artery disease	3.06e-05	0.000282	CcSEcCtD
Metolazone—Abdominal pain—Lisinopril—coronary artery disease	3.06e-05	0.000282	CcSEcCtD
Metolazone—Pruritus—Ramipril—coronary artery disease	3.02e-05	0.000279	CcSEcCtD
Metolazone—Asthenia—Timolol—coronary artery disease	2.99e-05	0.000276	CcSEcCtD
Metolazone—Nausea—Losartan—coronary artery disease	2.95e-05	0.000273	CcSEcCtD
Metolazone—Pruritus—Timolol—coronary artery disease	2.95e-05	0.000272	CcSEcCtD
Metolazone—Diarrhoea—Ramipril—coronary artery disease	2.92e-05	0.000269	CcSEcCtD
Metolazone—Diarrhoea—Timolol—coronary artery disease	2.85e-05	0.000263	CcSEcCtD
Metolazone—Hypersensitivity—Lisinopril—coronary artery disease	2.85e-05	0.000263	CcSEcCtD
Metolazone—Dizziness—Ramipril—coronary artery disease	2.82e-05	0.00026	CcSEcCtD
Metolazone—Asthenia—Lisinopril—coronary artery disease	2.77e-05	0.000256	CcSEcCtD
Metolazone—Dizziness—Timolol—coronary artery disease	2.76e-05	0.000255	CcSEcCtD
Metolazone—Pruritus—Lisinopril—coronary artery disease	2.74e-05	0.000253	CcSEcCtD
Metolazone—Vomiting—Ramipril—coronary artery disease	2.71e-05	0.00025	CcSEcCtD
Metolazone—Rash—Ramipril—coronary artery disease	2.69e-05	0.000248	CcSEcCtD
Metolazone—Dermatitis—Ramipril—coronary artery disease	2.69e-05	0.000248	CcSEcCtD
Metolazone—Headache—Ramipril—coronary artery disease	2.67e-05	0.000247	CcSEcCtD
Metolazone—Vomiting—Timolol—coronary artery disease	2.65e-05	0.000245	CcSEcCtD
Metolazone—Diarrhoea—Lisinopril—coronary artery disease	2.65e-05	0.000244	CcSEcCtD
Metolazone—Rash—Timolol—coronary artery disease	2.63e-05	0.000243	CcSEcCtD
Metolazone—Dermatitis—Timolol—coronary artery disease	2.63e-05	0.000242	CcSEcCtD
Metolazone—Headache—Timolol—coronary artery disease	2.61e-05	0.000241	CcSEcCtD
Metolazone—Dizziness—Lisinopril—coronary artery disease	2.56e-05	0.000236	CcSEcCtD
Metolazone—Nausea—Ramipril—coronary artery disease	2.53e-05	0.000234	CcSEcCtD
Metolazone—Nausea—Timolol—coronary artery disease	2.48e-05	0.000229	CcSEcCtD
Metolazone—Vomiting—Lisinopril—coronary artery disease	2.46e-05	0.000227	CcSEcCtD
Metolazone—Rash—Lisinopril—coronary artery disease	2.44e-05	0.000225	CcSEcCtD
Metolazone—Dermatitis—Lisinopril—coronary artery disease	2.44e-05	0.000225	CcSEcCtD
Metolazone—Headache—Lisinopril—coronary artery disease	2.42e-05	0.000224	CcSEcCtD
Metolazone—Nausea—Lisinopril—coronary artery disease	2.3e-05	0.000212	CcSEcCtD
Metolazone—CA9—Metabolism—LCAT—coronary artery disease	1.9e-05	0.000426	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPA—coronary artery disease	1.9e-05	0.000425	CbGpPWpGaD
Metolazone—CA12—Metabolism—LIPC—coronary artery disease	1.89e-05	0.000423	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2C19—coronary artery disease	1.89e-05	0.000423	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3C2A—coronary artery disease	1.89e-05	0.000423	CbGpPWpGaD
Metolazone—CA12—Metabolism—HBA1—coronary artery disease	1.89e-05	0.000423	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.89e-05	0.000422	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOC3—coronary artery disease	1.88e-05	0.00042	CbGpPWpGaD
Metolazone—CA12—Metabolism—LDLR—coronary artery disease	1.87e-05	0.000418	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA4—coronary artery disease	1.87e-05	0.000418	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTT1—coronary artery disease	1.84e-05	0.000413	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC9A1—coronary artery disease	1.84e-05	0.000413	CbGpPWpGaD
Metolazone—CA7—Metabolism—PSMB5—coronary artery disease	1.84e-05	0.000412	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PSMA6—coronary artery disease	1.84e-05	0.000412	CbGpPWpGaD
Metolazone—CA7—Metabolism—PSMA6—coronary artery disease	1.84e-05	0.000412	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PSMB5—coronary artery disease	1.84e-05	0.000412	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLCB3—coronary artery disease	1.84e-05	0.000411	CbGpPWpGaD
Metolazone—CA12—Metabolism—GCLC—coronary artery disease	1.82e-05	0.000408	CbGpPWpGaD
Metolazone—CA12—Metabolism—CETP—coronary artery disease	1.82e-05	0.000408	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA5—coronary artery disease	1.82e-05	0.000407	CbGpPWpGaD
Metolazone—CA12—Metabolism—SDC1—coronary artery disease	1.8e-05	0.000404	CbGpPWpGaD
Metolazone—CA9—Metabolism—PDHA1—coronary artery disease	1.8e-05	0.000404	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCLM—coronary artery disease	1.8e-05	0.000404	CbGpPWpGaD
Metolazone—CA7—Metabolism—CTGF—coronary artery disease	1.8e-05	0.000402	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CTGF—coronary artery disease	1.8e-05	0.000402	CbGpPWpGaD
Metolazone—CA4—Metabolism—P4HB—coronary artery disease	1.78e-05	0.000399	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMGCR—coronary artery disease	1.78e-05	0.000398	CbGpPWpGaD
Metolazone—CA7—Metabolism—GOT2—coronary artery disease	1.78e-05	0.000398	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMGCR—coronary artery disease	1.78e-05	0.000398	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GOT2—coronary artery disease	1.78e-05	0.000398	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLCB1—coronary artery disease	1.75e-05	0.000392	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLA2G1B—coronary artery disease	1.75e-05	0.000392	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP11B2—coronary artery disease	1.75e-05	0.000391	CbGpPWpGaD
Metolazone—CA9—Metabolism—TXNRD1—coronary artery disease	1.75e-05	0.000391	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC22A3—coronary artery disease	1.72e-05	0.000385	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CXCL8—coronary artery disease	1.72e-05	0.000385	CbGpPWpGaD
Metolazone—CA12—Metabolism—PSMA6—coronary artery disease	1.7e-05	0.000381	CbGpPWpGaD
Metolazone—CA12—Metabolism—PSMB5—coronary artery disease	1.7e-05	0.000381	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCA1—coronary artery disease	1.7e-05	0.00038	CbGpPWpGaD
Metolazone—CA9—Metabolism—ARNTL—coronary artery disease	1.69e-05	0.000379	CbGpPWpGaD
Metolazone—CA9—Metabolism—HADH—coronary artery disease	1.69e-05	0.000379	CbGpPWpGaD
Metolazone—CA12—Metabolism—CTGF—coronary artery disease	1.66e-05	0.000373	CbGpPWpGaD
Metolazone—CA4—Metabolism—VCAN—coronary artery disease	1.65e-05	0.000369	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMGCR—coronary artery disease	1.65e-05	0.000369	CbGpPWpGaD
Metolazone—CA12—Metabolism—GOT2—coronary artery disease	1.65e-05	0.000369	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GOT1—coronary artery disease	1.65e-05	0.000368	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GGT1—coronary artery disease	1.65e-05	0.000368	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALDOA—coronary artery disease	1.64e-05	0.000367	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLCB1—coronary artery disease	1.64e-05	0.000366	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLCB1—coronary artery disease	1.64e-05	0.000366	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX2—coronary artery disease	1.61e-05	0.00036	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA2—coronary artery disease	1.61e-05	0.00036	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G2A—coronary artery disease	1.61e-05	0.00036	CbGpPWpGaD
Metolazone—CA4—Metabolism—DCN—coronary artery disease	1.59e-05	0.000356	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX4—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA9—Metabolism—SULT1A1—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG5—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA9—Metabolism—HK1—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCA1—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCA1—coronary artery disease	1.59e-05	0.000355	CbGpPWpGaD
Metolazone—CA9—Metabolism—HADHA—coronary artery disease	1.57e-05	0.000351	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA1—coronary artery disease	1.55e-05	0.000347	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALDH2—coronary artery disease	1.55e-05	0.000346	CbGpPWpGaD
Metolazone—CA7—Metabolism—GOT1—coronary artery disease	1.54e-05	0.000344	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GGT1—coronary artery disease	1.54e-05	0.000344	CbGpPWpGaD
Metolazone—CA7—Metabolism—GGT1—coronary artery disease	1.54e-05	0.000344	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GOT1—coronary artery disease	1.54e-05	0.000344	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPA—coronary artery disease	1.53e-05	0.000343	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLCB1—coronary artery disease	1.52e-05	0.000339	CbGpPWpGaD
Metolazone—CA4—Metabolism—LIPC—coronary artery disease	1.51e-05	0.000337	CbGpPWpGaD
Metolazone—CA4—Metabolism—HBA1—coronary artery disease	1.51e-05	0.000337	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2C19—coronary artery disease	1.51e-05	0.000337	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3C2A—coronary artery disease	1.51e-05	0.000337	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOC3—coronary artery disease	1.5e-05	0.000335	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—coronary artery disease	1.49e-05	0.000335	CbGpPWpGaD
Metolazone—CA4—Metabolism—LDLR—coronary artery disease	1.49e-05	0.000333	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB3—coronary artery disease	1.48e-05	0.000332	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTP1—coronary artery disease	1.48e-05	0.000331	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTT1—coronary artery disease	1.47e-05	0.000329	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC9A1—coronary artery disease	1.47e-05	0.000329	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCA1—coronary artery disease	1.47e-05	0.000329	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA5—coronary artery disease	1.47e-05	0.000329	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARGC1A—coronary artery disease	1.46e-05	0.000328	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMOX1—coronary artery disease	1.46e-05	0.000326	CbGpPWpGaD
Metolazone—CA4—Metabolism—CETP—coronary artery disease	1.45e-05	0.000326	CbGpPWpGaD
Metolazone—CA4—Metabolism—GCLC—coronary artery disease	1.45e-05	0.000326	CbGpPWpGaD
Metolazone—CA9—Metabolism—P4HB—coronary artery disease	1.44e-05	0.000323	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAT—coronary artery disease	1.44e-05	0.000322	CbGpPWpGaD
Metolazone—CA4—Metabolism—SDC1—coronary artery disease	1.44e-05	0.000322	CbGpPWpGaD
Metolazone—CA12—Metabolism—GGT1—coronary artery disease	1.42e-05	0.000319	CbGpPWpGaD
Metolazone—CA12—Metabolism—GOT1—coronary artery disease	1.42e-05	0.000319	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G1B—coronary artery disease	1.41e-05	0.000317	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOB—coronary artery disease	1.4e-05	0.000313	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—coronary artery disease	1.4e-05	0.000312	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTP1—coronary artery disease	1.38e-05	0.000309	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTP1—coronary artery disease	1.38e-05	0.000309	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARGC1A—coronary artery disease	1.37e-05	0.000306	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARGC1A—coronary artery disease	1.37e-05	0.000306	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMOX1—coronary artery disease	1.36e-05	0.000305	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—coronary artery disease	1.36e-05	0.000305	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—coronary artery disease	1.36e-05	0.000304	CbGpPWpGaD
Metolazone—CA4—Metabolism—PSMB5—coronary artery disease	1.36e-05	0.000304	CbGpPWpGaD
Metolazone—CA4—Metabolism—PSMA6—coronary artery disease	1.36e-05	0.000304	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAT—coronary artery disease	1.34e-05	0.000301	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAT—coronary artery disease	1.34e-05	0.000301	CbGpPWpGaD
Metolazone—CA9—Metabolism—VCAN—coronary artery disease	1.33e-05	0.000299	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPL—coronary artery disease	1.33e-05	0.000299	CbGpPWpGaD
Metolazone—CA4—Metabolism—CTGF—coronary artery disease	1.33e-05	0.000297	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDOA—coronary artery disease	1.32e-05	0.000296	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMGCR—coronary artery disease	1.31e-05	0.000294	CbGpPWpGaD
Metolazone—CA4—Metabolism—GOT2—coronary artery disease	1.31e-05	0.000294	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOB—coronary artery disease	1.3e-05	0.000292	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOB—coronary artery disease	1.3e-05	0.000292	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—coronary artery disease	1.3e-05	0.000291	CbGpPWpGaD
Metolazone—CA9—Metabolism—DCN—coronary artery disease	1.28e-05	0.000288	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTP1—coronary artery disease	1.28e-05	0.000286	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—coronary artery disease	1.27e-05	0.000284	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—coronary artery disease	1.27e-05	0.000284	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CD36—coronary artery disease	1.27e-05	0.000284	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARGC1A—coronary artery disease	1.27e-05	0.000284	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMOX1—coronary artery disease	1.26e-05	0.000282	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK1—coronary artery disease	1.26e-05	0.000281	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPP2CA—coronary artery disease	1.25e-05	0.00028	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDH2—coronary artery disease	1.25e-05	0.00028	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPL—coronary artery disease	1.24e-05	0.000279	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPL—coronary artery disease	1.24e-05	0.000279	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAT—coronary artery disease	1.24e-05	0.000279	CbGpPWpGaD
Metolazone—CA9—Metabolism—LIPC—coronary artery disease	1.22e-05	0.000273	CbGpPWpGaD
Metolazone—CA9—Metabolism—HBA1—coronary artery disease	1.22e-05	0.000273	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2C19—coronary artery disease	1.22e-05	0.000273	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3C2A—coronary artery disease	1.22e-05	0.000273	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—coronary artery disease	1.21e-05	0.000272	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—coronary artery disease	1.21e-05	0.000272	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOC3—coronary artery disease	1.21e-05	0.000271	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLCB1—coronary artery disease	1.21e-05	0.000271	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOB—coronary artery disease	1.21e-05	0.00027	CbGpPWpGaD
Metolazone—CA9—Metabolism—LDLR—coronary artery disease	1.2e-05	0.000269	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—coronary artery disease	1.2e-05	0.000269	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTT1—coronary artery disease	1.19e-05	0.000266	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC9A1—coronary artery disease	1.19e-05	0.000266	CbGpPWpGaD
Metolazone—CA7—Metabolism—CD36—coronary artery disease	1.18e-05	0.000265	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CD36—coronary artery disease	1.18e-05	0.000265	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCLC—coronary artery disease	1.17e-05	0.000263	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—coronary artery disease	1.17e-05	0.000263	CbGpPWpGaD
Metolazone—CA9—Metabolism—CETP—coronary artery disease	1.17e-05	0.000263	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCA1—coronary artery disease	1.17e-05	0.000262	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPP2CA—coronary artery disease	1.17e-05	0.000261	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPP2CA—coronary artery disease	1.17e-05	0.000261	CbGpPWpGaD
Metolazone—CA9—Metabolism—SDC1—coronary artery disease	1.16e-05	0.00026	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPL—coronary artery disease	1.15e-05	0.000258	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AGT—coronary artery disease	1.14e-05	0.000255	CbGpPWpGaD
Metolazone—CA4—Metabolism—GGT1—coronary artery disease	1.14e-05	0.000254	CbGpPWpGaD
Metolazone—CA4—Metabolism—GOT1—coronary artery disease	1.14e-05	0.000254	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—coronary artery disease	1.13e-05	0.000252	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—coronary artery disease	1.12e-05	0.000251	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—coronary artery disease	1.12e-05	0.000251	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOE—coronary artery disease	1.12e-05	0.00025	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOA1—coronary artery disease	1.1e-05	0.000247	CbGpPWpGaD
Metolazone—CA9—Metabolism—PSMB5—coronary artery disease	1.1e-05	0.000246	CbGpPWpGaD
Metolazone—CA9—Metabolism—PSMA6—coronary artery disease	1.1e-05	0.000246	CbGpPWpGaD
Metolazone—CA12—Metabolism—CD36—coronary artery disease	1.1e-05	0.000245	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPP2CA—coronary artery disease	1.08e-05	0.000242	CbGpPWpGaD
Metolazone—CA9—Metabolism—CTGF—coronary artery disease	1.07e-05	0.00024	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AGT—coronary artery disease	1.06e-05	0.000238	CbGpPWpGaD
Metolazone—CA7—Metabolism—AGT—coronary artery disease	1.06e-05	0.000238	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMGCR—coronary artery disease	1.06e-05	0.000238	CbGpPWpGaD
Metolazone—CA9—Metabolism—GOT2—coronary artery disease	1.06e-05	0.000238	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOE—coronary artery disease	1.04e-05	0.000234	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOE—coronary artery disease	1.04e-05	0.000234	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—coronary artery disease	1.04e-05	0.000232	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA1—coronary artery disease	1.03e-05	0.000231	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA1—coronary artery disease	1.03e-05	0.000231	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTP1—coronary artery disease	1.02e-05	0.000228	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARGC1A—coronary artery disease	1.01e-05	0.000226	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—coronary artery disease	1.01e-05	0.000225	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAT—coronary artery disease	9.92e-06	0.000222	CbGpPWpGaD
Metolazone—CA12—Metabolism—AGT—coronary artery disease	9.87e-06	0.000221	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB1—coronary artery disease	9.77e-06	0.000219	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARG—coronary artery disease	9.73e-06	0.000218	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOE—coronary artery disease	9.67e-06	0.000216	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—coronary artery disease	9.65e-06	0.000216	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOB—coronary artery disease	9.63e-06	0.000216	CbGpPWpGaD
Metolazone—CA5A—Metabolism—POMC—coronary artery disease	9.6e-06	0.000215	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA1—coronary artery disease	9.56e-06	0.000214	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCA1—coronary artery disease	9.47e-06	0.000212	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—coronary artery disease	9.37e-06	0.00021	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPL—coronary artery disease	9.2e-06	0.000206	CbGpPWpGaD
Metolazone—CA9—Metabolism—GGT1—coronary artery disease	9.17e-06	0.000205	CbGpPWpGaD
Metolazone—CA9—Metabolism—GOT1—coronary artery disease	9.17e-06	0.000205	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARG—coronary artery disease	9.09e-06	0.000203	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARG—coronary artery disease	9.09e-06	0.000203	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—coronary artery disease	8.97e-06	0.000201	CbGpPWpGaD
Metolazone—CA7—Metabolism—POMC—coronary artery disease	8.96e-06	0.000201	CbGpPWpGaD
Metolazone—CA5B—Metabolism—POMC—coronary artery disease	8.96e-06	0.000201	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—coronary artery disease	8.75e-06	0.000196	CbGpPWpGaD
Metolazone—CA4—Metabolism—CD36—coronary artery disease	8.74e-06	0.000196	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPP2CA—coronary artery disease	8.63e-06	0.000193	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARG—coronary artery disease	8.42e-06	0.000189	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—coronary artery disease	8.37e-06	0.000187	CbGpPWpGaD
Metolazone—CA12—Metabolism—POMC—coronary artery disease	8.3e-06	0.000186	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—coronary artery disease	8.28e-06	0.000185	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTP1—coronary artery disease	8.24e-06	0.000184	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—coronary artery disease	8.17e-06	0.000183	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—coronary artery disease	8.17e-06	0.000183	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARGC1A—coronary artery disease	8.16e-06	0.000183	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—coronary artery disease	8.12e-06	0.000182	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAT—coronary artery disease	8.02e-06	0.000179	CbGpPWpGaD
Metolazone—CA4—Metabolism—AGT—coronary artery disease	7.87e-06	0.000176	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—coronary artery disease	7.82e-06	0.000175	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—coronary artery disease	7.82e-06	0.000175	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOB—coronary artery disease	7.78e-06	0.000174	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOE—coronary artery disease	7.71e-06	0.000173	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—coronary artery disease	7.66e-06	0.000171	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA1—coronary artery disease	7.62e-06	0.000171	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—coronary artery disease	7.57e-06	0.00017	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—coronary artery disease	7.57e-06	0.00017	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPL—coronary artery disease	7.43e-06	0.000166	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—coronary artery disease	7.25e-06	0.000162	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—coronary artery disease	7.24e-06	0.000162	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—coronary artery disease	7.15e-06	0.00016	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—coronary artery disease	7.15e-06	0.00016	CbGpPWpGaD
Metolazone—CA9—Metabolism—CD36—coronary artery disease	7.06e-06	0.000158	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPP2CA—coronary artery disease	6.97e-06	0.000156	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARG—coronary artery disease	6.71e-06	0.00015	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—coronary artery disease	6.69e-06	0.00015	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—coronary artery disease	6.62e-06	0.000148	CbGpPWpGaD
Metolazone—CA4—Metabolism—POMC—coronary artery disease	6.62e-06	0.000148	CbGpPWpGaD
Metolazone—CA9—Metabolism—AGT—coronary artery disease	6.36e-06	0.000142	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOE—coronary artery disease	6.23e-06	0.000139	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA1—coronary artery disease	6.16e-06	0.000138	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—coronary artery disease	6.04e-06	0.000135	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—coronary artery disease	5.77e-06	0.000129	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARG—coronary artery disease	5.43e-06	0.000121	CbGpPWpGaD
Metolazone—CA9—Metabolism—POMC—coronary artery disease	5.35e-06	0.00012	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—coronary artery disease	5.28e-06	0.000118	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—coronary artery disease	4.88e-06	0.000109	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—coronary artery disease	4.71e-06	0.000105	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—coronary artery disease	4.67e-06	0.000104	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—coronary artery disease	4.4e-06	9.85e-05	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—coronary artery disease	4.4e-06	9.85e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—coronary artery disease	4.27e-06	9.56e-05	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—coronary artery disease	4.07e-06	9.12e-05	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—coronary artery disease	3.85e-06	8.62e-05	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—coronary artery disease	3.59e-06	8.05e-05	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—coronary artery disease	3.59e-06	8.05e-05	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—coronary artery disease	3.33e-06	7.45e-05	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—coronary artery disease	3.25e-06	7.28e-05	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—coronary artery disease	2.65e-06	5.94e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—coronary artery disease	2.63e-06	5.88e-05	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—coronary artery disease	2.15e-06	4.8e-05	CbGpPWpGaD
